MedTrace Logo

Effectiveness of Antibiotic Prophylaxis for Totally Implantable Venous Access Device

NCT00867295 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2010-06-02

No results posted yet for this study

Summary

This randomized trial is determining the role of antibiotic prophylaxis in the prevention of the infectious complications in patients carrying out totally implantable venous access device.

Conditions

Interventions

DRUG

cefazolin Sodium

cefazolin Sodium 1g i.v. before operation

DRUG

placebo

placebo

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Hasan Karanlik, MD · Istanbul University Institute of Oncology Department of Surgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-12-31
Completion
2010-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00867295 on ClinicalTrials.gov